Literature DB >> 19853416

Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis.

Päivikki Tanskanen1, Marianne Haapea, Juha Veijola, Jouko Miettunen, Marjo-Riitta Järvelin, Juhani Pyhtinen, Peter B Jones, Matti Isohanni.   

Abstract

Magnetic resonance imaging (MRI) studies in schizophrenia have seldom involved a general population birth cohort or other epidemiological samples. We studied the Northern Finland 1966 Birth Cohort and identified all people with psychotic disorders. Along with an unaffected age-matched control sample (n = 100) from the cohort, 54 subjects with schizophrenia underwent MRI brain scan at age 33-35 years from which we defined volumes of whole brain, grey and white matter and intracranial cerebrospinal fluid (CSF). Whole brain, grey and white matter volumes were 2-3% smaller in the schizophrenia subjects, who showed a 7% increase in CSF volume. These volume changes were independent of the effects of gender, family history of psychosis, perinatal risks or age at onset of illness. Moreover, there was no evidence that the effects were due to particular subgroups of cases having very low or high values. Rather, there were linear trends in the associations between whole brain and grey matter volume measures and schizophrenia. Our study replicates the previous findings of brain volume differences in schizophrenia on a general population level.

Entities:  

Mesh:

Year:  2009        PMID: 19853416     DOI: 10.1016/j.pscychresns.2009.04.009

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

2.  Delayed white matter growth trajectory in young nonpsychotic siblings of patients with childhood-onset schizophrenia.

Authors:  Nitin Gogtay; Xue Hua; Reva Stidd; Christina P Boyle; Suh Lee; Brian Weisinger; Alex Chavez; Jay N Giedd; Liv Clasen; Arthur W Toga; Judith L Rapoport; Paul M Thompson
Journal:  Arch Gen Psychiatry       Date:  2012-09

3.  Brain size and brain/intracranial volume ratio in major mental illness.

Authors:  Martin Reite; Erik Reite; Dan Collins; Peter Teale; Donald C Rojas; Elliot Sandberg
Journal:  BMC Psychiatry       Date:  2010-10-11       Impact factor: 3.630

Review 4.  Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review.

Authors:  Erika Jääskeläinen; Marianne Haapea; Nina Rautio; Pauliina Juola; Matti Penttilä; Tanja Nordström; Ina Rissanen; Anja Husa; Emmi Keskinen; Riikka Marttila; Svetlana Filatova; Tiina-Mari Paaso; Jenni Koivukangas; Kristiina Moilanen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Res Treatment       Date:  2015-05-18

5.  Neuroanatomical Abnormalities in Violent Individuals with and without a Diagnosis of Schizophrenia.

Authors:  Victor A Del Bene; John J Foxe; Lars A Ross; Menahem I Krakowski; Pal Czobor; Pierfilippo De Sanctis
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

6.  Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.

Authors:  Juha Veijola; Joyce Y Guo; Jani S Moilanen; Erika Jääskeläinen; Jouko Miettunen; Merja Kyllönen; Marianne Haapea; Sanna Huhtaniska; Antti Alaräisänen; Pirjo Mäki; Vesa Kiviniemi; Juha Nikkinen; Tuomo Starck; Jukka J Remes; Päivikki Tanskanen; Osmo Tervonen; Alle-Meije Wink; Angie Kehagia; John Suckling; Hiroyuki Kobayashi; Jennifer H Barnett; Anna Barnes; Hannu J Koponen; Peter B Jones; Matti Isohanni; Graham K Murray
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

7.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.